Roman Health
2017
FOUNDED
PRIVATE
STATUS
61-70
EMPLOYEES
Series B1
LATEST DEAL TYPE
$85M
LATEST DEAL AMOUNT
21
INVESTORS
Description
Developer of a direct-to-consumer telehealth company intended to handle everything from diagnosis to the convenient delivery of medication. The company allows people to get in touch with physicians and has two end-to-end services, one for erectile dysfunction and the other to help people quit smoking, providing users with access to free medication delivery and personalized treatment
Website
Formerly Known As
Roman Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Primary Office
- 900 Broadway
- Suite 706
- New York, NY 10003
- United States
+1 (888) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Roman Health’s full profile, request a free trial.
Roman Health Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B1) | 06-Mar-2019 | $85M | 00000 | 00000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 18-Sep-2018 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
| 1. Seed Round | 17-Aug-2017 | $3.1M | $3.1M | 000.00 | Completed | Generating Revenue |
Roman Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A | 4,419,929 | $0.000100 | $0.37 | $4.57 | $4.57 | 1x | $4.57 | 13.16% |
| Seed | 3,182,504 | $0.000100 | $0.08 | $0.99 | $0.99 | 1x | $0.99 | 9.48% |
Roman Health Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000000000000 | Venture Capital-Backed | Denver, CO | 000 | 000.00 | 00000000000 | 000.00 |
Roman Health Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Canaan Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| PROOF Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| FirstMark Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Rosecliff Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SignalFire | Venture Capital | Minority | 000 0000 | 000000 0 |
Roman Health Executive Team (4)
Roman Health Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alexis Ohanian | Initialized Capital Management | Board Member | 000 0000 | |
| Richard Heitzmann | FirstMark Capital | Board Member | 000 0000 | |
| Robert Schutz | Roman Health | Co-Founder & Board Member | 000 0000 | |
| Saman Rahmanian | Roman Health | Co-Founder & Board Member | 000 0000 |